240 related articles for article (PubMed ID: 11856307)
1. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat.
Silhol M; Tyagi M; Giacca M; Lebleu B; Vivès E
Eur J Biochem; 2002 Jan; 269(2):494-501. PubMed ID: 11856307
[TBL] [Abstract][Full Text] [Related]
2. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans.
Tyagi M; Rusnati M; Presta M; Giacca M
J Biol Chem; 2001 Feb; 276(5):3254-61. PubMed ID: 11024024
[TBL] [Abstract][Full Text] [Related]
3. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
4. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.
Vivès E; Brodin P; Lebleu B
J Biol Chem; 1997 Jun; 272(25):16010-7. PubMed ID: 9188504
[TBL] [Abstract][Full Text] [Related]
5. TAT peptide internalization: seeking the mechanism of entry.
Vivès E; Richard JP; Rispal C; Lebleu B
Curr Protein Pept Sci; 2003 Apr; 4(2):125-32. PubMed ID: 12678851
[TBL] [Abstract][Full Text] [Related]
6. Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide.
Kim A; Shin TH; Shin SM; Pham CD; Choi DK; Kwon MH; Kim YS
PLoS One; 2012; 7(12):e51813. PubMed ID: 23251631
[TBL] [Abstract][Full Text] [Related]
7. Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time.
Ferrari A; Pellegrini V; Arcangeli C; Fittipaldi A; Giacca M; Beltram F
Mol Ther; 2003 Aug; 8(2):284-94. PubMed ID: 12907151
[TBL] [Abstract][Full Text] [Related]
8. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions.
Vives E
J Mol Recognit; 2003; 16(5):265-71. PubMed ID: 14523939
[TBL] [Abstract][Full Text] [Related]
10. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
Albarran B; To R; Stayton PS
Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
[TBL] [Abstract][Full Text] [Related]
11. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors.
Richard JP; Melikov K; Brooks H; Prevot P; Lebleu B; Chernomordik LV
J Biol Chem; 2005 Apr; 280(15):15300-6. PubMed ID: 15687490
[TBL] [Abstract][Full Text] [Related]
12. Intracellular delivery of artificial transcription factors fused to the protein transduction domain of HIV-1 Tat.
Zhao X; Dong Y; Zhao Z; Guo J; Liu J; Huang P; Dong D; Fan H; Guo Q; Yang X; Xu J; Li J; Fu L; Chen W
Protein Expr Purif; 2013 Jul; 90(1):27-33. PubMed ID: 23648869
[TBL] [Abstract][Full Text] [Related]
13. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells.
Tünnemann G; Martin RM; Haupt S; Patsch C; Edenhofer F; Cardoso MC
FASEB J; 2006 Sep; 20(11):1775-84. PubMed ID: 16940149
[TBL] [Abstract][Full Text] [Related]
14. Direct interaction of human TFIID with the HIV-1 transactivator tat.
Kashanchi F; Piras G; Radonovich MF; Duvall JF; Fattaey A; Chiang CM; Roeder RG; Brady JN
Nature; 1994 Jan; 367(6460):295-9. PubMed ID: 8121496
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors.
Yang Y; Ma J; Song Z; Wu M
FEBS Lett; 2002 Dec; 532(1-2):36-44. PubMed ID: 12459459
[TBL] [Abstract][Full Text] [Related]
16. Can the Cellular Internalization of Cargo Proteins Be Enhanced by Fusing a Tat Peptide in the Center of Proteins? A Fluorescence Study.
Chen X; Chen J; Fu R; Rao P; Weller R; Bradshaw J; Liu S
J Pharm Sci; 2018 Mar; 107(3):879-886. PubMed ID: 29133235
[TBL] [Abstract][Full Text] [Related]
17. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
[TBL] [Abstract][Full Text] [Related]
18. Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide.
Zhang X; Jin Y; Plummer MR; Pooyan S; Gunaseelan S; Sinko PJ
Mol Pharm; 2009; 6(3):836-48. PubMed ID: 19278221
[TBL] [Abstract][Full Text] [Related]
19. Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors.
Al-Taei S; Penning NA; Simpson JC; Futaki S; Takeuchi T; Nakase I; Jones AT
Bioconjug Chem; 2006; 17(1):90-100. PubMed ID: 16417256
[TBL] [Abstract][Full Text] [Related]
20. Structural and dynamic properties of the HIV-1 tat transduction domain in the free and heparin-bound states.
Hakansson S; Caffrey M
Biochemistry; 2003 Aug; 42(30):8999-9006. PubMed ID: 12885232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
